Sue Washer | President and Chief Executive Officer |
Matthew Feinsod | Chief Medical Officer |
William Sullivan | Chief Financial Officer |
Matthew Luchini | BMO Capital Markets |
Natalya Gertsik | Chardan Capital Markets, LLC |
Good morning, and welcome to the AGTC Second Quarter Fiscal Year 2019 Financial Results Conference Call. Today's call is being recorded.
Before we get started, I'd like to remind everyone that during this conference call AGTC may make forward-looking statements, including statements about the company's financial results, financial guidance, its future business strategies and operations, and its product development and regulatory process. Actual results could differ materially from those discussed in these forward-looking statements due to a number of important factors, including uncertainty inherent in clinical development and regulatory process and other risks described in the Risk Factors section of AGTC's annual report on Form 10-K for the fiscal year ended June 30, 2018.
For introductions and opening remarks, I'd like to turn the call over to Sue Washer, Chief Executive Officer of AGTC.